Purpose: Based on the prospective analysis of data on 680 patients und
ergoing surgery for nonruptured abdominal aortic aneurysm (AAA) and re
corded in the Canadian Society for Vascular Surgery Aneurysm Registry,
this study determines the late survival rate by comparison to an age-
and sex-matched population, the causes of late death, the effect of h
eart-related death on late survival, and the prognostic variables that
are associated with late survival. Methods: To identify the variables
that were associated with survival, statistical methods included Kapl
an-Meier analysis and Cox regression analysis. The Canadian Society fo
r Vascular Surgery Aneurysm Registry provided ongoing current follow-u
p of patients. Results: The survival rate was 94.6% at 1 month, 90.7%
at 1 year, 87.1% at 2 years, 81.0% at 3 years, 74.0% at 4 years, 67.7%
at 5 years, and 60.2% at 6 years. The late survival rate of patients
with AAA is significantly less than the age- and sex-matched normal po
pulation (60.2% versus 79.2%). In the AAA group, heart-related causes
of late death (44.4% versus 34.1%) and cerebrovascular causes (8.3% ve
rsus 5.8%) were more frequent. The calculated 5-year heart-related mor
tality rate is 14.3%. This is higher than the heart-related mortality
rate for the age- and sex-matched population, which is 6.4%. Hence, th
e risk of heart-related death for patients who have undergone AAA repa
ir is increased by 1.6% per year. Vascular complications from aortic a
neurysm repair or recurrent aneurysmal disease were an uncommon cause
of late death: ruptured thoracic aneurysm, 1.5%; ruptured aortic false
aneurysm, 1.5%; and aortoenteric fistula, 0%. This incidence appears
to be less than reported in earlier series. By Cox regression analysis
, the variables that were significant predictors of a lower late survi
val rate were increased age, preoperative electrocardiogram indicating
a previous myocardial infarction, and elevated serum creatinine level
s. Conclusions: Because cardiac complications accounted for 68.8% (22/
32) of the 4.7% in-hospital mortality rate (i.e., a heart-related mort
ality rate of 3.2%), it seems reasonable to develop a strategy to redu
ce the cardiac operative risk by identifying and treating patients at
high risk before operation. However, it is doubtful that a preoperativ
e program that screens and treats all patients can be cost-effective i
n preventing late heart-related deaths.